Saturday, October 15, 2016

How Mast Cell Activation Disorder and Histamine Intolerance May Be Affecting Your Recovery From Lyme Disease

When Infection Triggers an Auto-Inflammatory Reaction

Lyme disease is the fastest growing vector-borne disease in the U.S. today with an estimated 329,000 Americans affected annually. Studies have shown that anywhere from 10-60% of patients who are treated with a standard course of antibiotics for Lyme Disease, will have continuing, sometimes debilitating symptoms. The CDC calls this chronic condition "Post Treatment Lyme Disease Syndrome" (PTLDS). There is a growing body of evidence that demonstrates the reason for this condition may be due to an undiagnosed co-infection (like babesia bartonella, ehrlichia or anaplasma)[1] and/or treatment resistant Lyme bacteria, also known as persistent infection. (see my prior post on Lyme Persisters) The other possibility is that the infection triggers a dysfunction within the immune system. This can lead to an autoimmune or auto-inflammatory disease separate from or in addition to the infection. In this post I will be exploring how Lyme Disease can trigger an auto-inflammatory reaction through Mast Cell Activation.